Literature DB >> 27459517

[The 2-Scale Model of the National Eye Institute Visual Function Questionnaire (NEI-VFQ) to Assess Vision-Related Quality of Life].

D Brösel1, B A Sabel1, G H Franke2, C Gall2.   

Abstract

Aim This study addresses the examination of the factorial validity of the National Eye Institute Visual Function Questionnaire 39 (NEI-VFQ 39) and the neuro-ophthalmological supplement in a German sample. Method Eighty-one patients with visual field defects affecting at least one eye answered the NEI-VFQ 39 and the supplement. Theoretical factor structures reported in the manuals were examined in confirmatory factor analysis. Because of a misfit, items retained after item analysis were subjected to exploratory factor analysis. Results The originally postulated factor structures could not be replicated. Many items revealed floor effects. The 21 remaining items could be assigned to two factors - "visual functioning" and "socio-emotional impairment". Conclusion The weakness of the theoretical factors can be avoided by using the 2-scale model. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2016        PMID: 27459517     DOI: 10.1055/s-0042-109700

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  2 in total

1.  The National Eye Institute 25-Item Visual Function Questionnaire (NEI VFQ-25) - reference data from the German population-based Gutenberg Health Study (GHS).

Authors:  Stefan Nickels; Alexander K Schuster; Susanne Singer; Philipp S Wild; Dagmar Laubert-Reh; Andreas Schulz; Robert P Finger; Matthias Michal; Manfred E Beutel; Thomas Münzel; Karl J Lackner; Norbert Pfeiffer
Journal:  Health Qual Life Outcomes       Date:  2017-08-08       Impact factor: 3.186

2.  Topical Anesthesia Offers Sufficient Pain Control for MicroPulse Transscleral Laser Therapy for Glaucoma.

Authors:  Belgin Vasella; Marc Töteberg-Harms
Journal:  J Ophthalmol       Date:  2022-09-21       Impact factor: 1.974

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.